Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. (Q54051042)

24 May 2018

title

Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. (English)

1 reference

24 May 2018

1 reference

Enterococcus faecium

1 reference

Winston DJ

1

1 reference

24 May 2018

Emmanouilides C

2

1 reference

24 May 2018

Kroeber A

3

1 reference

24 May 2018

Hindler J

4

1 reference

24 May 2018

Bruckner DA

5

1 reference

24 May 2018

Territo MC

6

1 reference

24 May 2018

Busuttil RW

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

18 May 2000

1 reference

24 May 2018

Clinical Infectious Diseases

published in

1 reference

24 May 2018

volume

30

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

790-797

1 reference

24 May 2018

Management of the behavioral manifestations of dementia

cites work

1 reference

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

21 January 2018

1 reference

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit

21 January 2018

1 reference

The challenge of vancomycin-resistant enterococci: A clinical and epidemiologic study

21 January 2018

1 reference

Natural history of colonization with vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality

21 January 2018

1 reference

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

21 January 2018

1 reference

An old antibiotic for a new multiple-resistant Enterococcus faecium?

21 January 2018

1 reference

Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin

21 January 2018

1 reference

Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium

21 January 2018

1 reference

Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience

21 January 2018

1 reference

In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.

21 January 2018

1 reference

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

21 January 2018

1 reference

Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort

21 January 2018

1 reference

Risk factors for mortality associated with enterococcal bloodstream infections.

21 January 2018

1 reference

Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

21 January 2018

1 reference

Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin

21 January 2018

1 reference

Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313766

1 reference

24 May 2018

1 reference

24 May 2018